EPIDERMAL GROWTH FACTOR MODULATES CELL ATTACHMENT TO HYALURONIC ACID BY THE CELL SURFACE GLYCOPROTEIN CD44

Alan Wells , Gene P. Siegal , Raj K. Singh , Ming Zhang
Clinical & Experimental Metastasis 14 ( 3) 268 -276

27
1996
Stearate inhibits breast cancer cell spreading, motility, and invasion

Joanne Murphy-Ullrich , Manuel Pallero , Stephanie Cowey , Robert W. Hardy
Cancer Research 66 427 -427

2006
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.

Manuel Gonzalez-Baron , Manuel Gonzalez-Baron , Akseli Hemminki , Candace J. Coolidge
Clinical Cancer Research 7 ( 8) 2496 -2504

54
2001
A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer

Akseli Hemminki , Martina Breidenbach , Martina Breidenbach , Masato Yamamoto
Clinical Cancer Research 11 ( 3) 1327 -1335

38
2005
Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.

Joseph C. Glorioso , Waleed O. Arafat , Enrique Casado , Gene P. Siegal
Clinical Cancer Research 6 ( 11) 4442 -4448

31
2000
Characterization of CXCR4 expression in chondrosarcoma of bone.

Gene P. Siegal , Dezhi Wang , Michael J. Klein , Shuting Bai
Archives of Pathology & Laboratory Medicine 135 ( 6) 753 -758

19
2011
Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

Andrew Berchuck , Gene P. Siegal , Masakuni Furusato , Yoshiteru Terashima
Cancer Research 53 ( 8) 1906 -1910

160
1993
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.

Akseli Hemminki , Manjula Kataram , Parameshwar J. Mahasreshti , Delicia Carey
Clinical Cancer Research 7 ( 7) 2057 -2066

81
2001
Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Gerald M. Fuller , Gene P. Siegal , Minghui Wang , David T. Curiel
Clinical Cancer Research 5 ( 1) 43 -50

30
1999
Intravenous Delivery of Adenovirus-mediated Soluble FLT-1 Results in Liver Toxicity

Cecil R. Stockard , Manjula Kataram , William E. Grizzle , Parameshwar J. Mahasreshti
Clinical Cancer Research 9 ( 7) 2701 -2710

63
2003
Reporting guidelines for clinical laboratory reports in surgical pathology.

Saul Suster , Thomas M. Wheeler , Richard W. Brown , Gene P. Siegal
Archives of Pathology & Laboratory Medicine 132 ( 10) 1608 -1616

27
2008
Telomerase-selective virotherapy with fluorescently labelled adenovirus for cervical cancer treatment

J. Michael Mathis , Takashi Matsumoto , Mariam A. Stoff-Khalili , Yosuke Kawakami
Cancer Research 66 704 -704

2006
Targeted Gene Delivery to Kaposi's Sarcoma Cells via the Fibroblast Growth Factor Receptor'

Barbara A. Sosnowski , Gene P. Siegal , Joanne T. Douglas , David T. Curiel
Cancer Research 57 ( 8) 1447 -1451

200
1997
Adeno-associated virus for cancer gene therapy.

Selvarangan Ponnazhagan , Gene P. Siegal , David T. Curiel , Ronald D. Alvarez
Cancer Research 61 ( 17) 6313 -6321

75
2001
Modulation of Coxsackie-Adenovirus Receptor Expression for Increased Adenoviral Transgene Expression

Anna Kanerva , Akseli Hemminki , Gene P. Siegal , Minghui Wang
Cancer Research 63 ( 4) 847 -853

93
2003
Novel gene therapy strategy to accomplish growth factor modulation induces enhanced tumor cell chemosensitivity.

Jessy S. Deshane , Gene P. Siegal , Mack N. Barnes , David T. Curiel
Clinical Cancer Research 2 ( 7) 1089 -1095

29
1996
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

Ramin B. Arani , Waleed Arafat , Theresa V. Strong , Martin R. Johnson
Clinical Cancer Research 6 ( 8) 3081 -3087

155
2000
Cytopathology of Bone and Soft Tissue Tumors

Nirag C. Jhala , Gene P. Siegal
Archives of Pathology & Laboratory Medicine 127 ( 2) 255 -255

2003
Osteosarcoma: anatomic and histologic variants.

Gene P. Siegal , Michael J. Klein
American Journal of Clinical Pathology 125 ( 4) 555 -581

270
2006